Effect of Carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial - The Lancet – 2001
Brief Summary:
In patients with acute MI and evidence of LV systolic dysfunction (EF < 40%), treatment with carvedilol is associated with decreased mortality.Reference:
http://www.ncbi.nlm.nih.gov/pubmed/11356434
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you